Kim H C, Weierbach R G, Friedman S, Schwartz E
Blood. 1977 May;49(5):785-92.
Globin synthesis studies are useful in the analysis of thalassemia syndromes. We have applied globin synthesis and free alpha-chain pool studies of peripheral blood to characterize hematologic disorders where alpha- or beta-thalassemia was present in combination with HbS or HbC. In 60 non-thalassemic controls, the beta/alpha specific activity ratio was 1.01 +/- 0.06 (SD). In three patients with HbS-beta0-thalassemia, the (betas + gamma)/alpha ratios were 0.48-.067. In four patients with HbSS-alpha-thalassemia, the (BETAS/ALPHA RATIO was 1.26 +/- 0.18 (1.13-1.53). The radioactive free alpha-chain pool in three patients with HbS-beta0-thalassemia was elevated (35.1%-53.0%), while three patients with HbSS-alpha-thalassemia had decreased free radioactive alpha-chain pools (3.2%-6.4%); both were significantly different from the mean (15.1% +/- 2.6%) of the 17 iron-sufficient controls. Simultaneous studies of the fraction of newly synthesized alpha chain contained in the free alpha-chain pool in peripheral blood and bone marrow demonstrated that this fraction was larger in peripheral blood than in marrow, and that the differences between thalassemia patients and controls previously found in bone marrow using these methods were also present in peripheral blood. The results indicate that even when family studies are not possible, patients with HbS in combination with alpha- or beta0-thalassemia can be differentiated from those with homozygous sickle cell disease by globin synthesis and free alpha-chain pool studies using peripheral blood.
珠蛋白合成研究在分析地中海贫血综合征方面很有用。我们已将外周血的珠蛋白合成和游离α链池研究应用于对存在α或β地中海贫血并伴有HbS或HbC的血液系统疾病进行特征描述。在60名非地中海贫血对照者中,β/α比活性为1.01±0.06(标准差)。在3例HbS-β0-地中海贫血患者中,(βs + γ)/α比值为0.48 - 0.67。在4例HbSS-α-地中海贫血患者中,β/α比值为1.26±0.18(1.13 - 1.53)。3例HbS-β0-地中海贫血患者的放射性游离α链池升高(35.1% - 53.0%),而3例HbSS-α-地中海贫血患者的游离放射性α链池降低(3.2% - 6.4%);两者均与17名铁充足对照者的平均值(15.1%±2.6%)有显著差异。对外周血和骨髓中游离α链池所含新合成α链比例的同步研究表明,外周血中的这一比例大于骨髓中的比例,并且使用这些方法先前在骨髓中发现的地中海贫血患者与对照者之间的差异在外周血中也存在。结果表明,即使无法进行家系研究,通过使用外周血进行珠蛋白合成和游离α链池研究,也可将伴有α或β0-地中海贫血的HbS患者与纯合镰状细胞病患者区分开来。